Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

(R, S)-3-(bromomethyl)-3-butanol-1-yl-diphosphate

EU orphan designation number: EU/3/04/218
Active ingredient: (R, S)-3-(bromomethyl)-3-butanol-1-yl-diphosphate
Indication: Treatment of renal cell carcinoma
Sponsor: Innate Pharma SAS
Grand Pré, 119/121 Ancien chemin de Cassis, F-13009 Marseille, France

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/08/2004 Centralised Orphan - Designation EMEA/OD/030/04 (2004)2996 of 29/07/2004
20/03/2006 Other procedure
26/08/2010 Centralised Orphan - Removal of orphan designation from Community Register